NVST

+ Watchlist + Portfolio

Envista Holdings Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $27.58
52-Week Range: $18.77 – $30.42
Market Cap: $4.33B
P/E (TTM): 46.43
EPS (TTM): 0.58
Dividend Yield: —

Advanced Metrics

Price/Book: 1.42
PEG Ratio: —
Return on Equity: 3.06%
Return on Assets: 3.37%
Gross Margin: 55.86%
Operating Margin: 12.11%
Profit Margin: 3.33%
Current Ratio: 2.42
Debt/Equity: 0.52
Total Debt: $1.59B
Free Cash Flow: $275.76M
Revenue Growth: 7.10%
Earnings Growth: 111.30%
Enterprise Value: $4.89B

NVST Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$2.57B	$2.57B	$2.51B	$2.72B
Cost of Revenue	$1.09B	$1.13B	$1.14B	$1.23B
Gross Profit	$1.47B	$1.44B	$1.37B	$1.49B
Research & Development	$100.10M	$93.80M	$99.10M	$114.00M
Selling, General & Admin	$1.03B	$1.03B	$1.14B	$1.14B
Operating Expenses	$1.13B	$1.13B	$1.24B	$1.25B
Operating Income	$343.20M	$314.90M	$137.20M	$235.80M
EBITDA	$484.40M	$171.10M	-$883.80M	$364.50M
Pretax Income	$283.90M	-$54.90M	-$1.08B	$177.20M
Income Tax	$45.90M	$45.30M	$33.90M	$130.20M
Net Income	$243.10M	-$100.20M	-$1.12B	$47.00M
Diluted EPS	1.37	-0.60	-6.50	0.28
Diluted Shares	177.60M	166.90M	172.20M	169.20M

NVST Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$606.90M	$940.00M	$1.07B	$1.21B
Receivables	$393.50M	$407.50M	$363.00M	$429.60M
Inventory	$300.80M	$258.80M	$241.00M	$288.10M
Current Assets	$1.42B	$1.74B	$1.79B	$2.03B
Total Assets	$6.59B	$6.61B	$5.35B	$5.68B
Current Liabilities	$1.24B	$780.80M	$878.70M	$852.60M
Long-Term Debt	$870.70M	$1.40B	$1.28B	$1.45B
Total Debt	$1.53B	$1.65B	$1.55B	$1.60B
Total Liabilities	$2.38B	$2.43B	$2.42B	$2.57B
Retained Earnings	$731.40M	$631.20M	-$487.40M	-$440.40M
Shareholders' Equity	$4.21B	$4.17B	$2.93B	$3.11B
Working Capital	$187.90M	$962.90M	$909.60M	$1.17B
Net Debt	$773.80M	$573.40M	$325.20M	$236.60M

NVST Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$182.70M	$275.70M	$336.50M	$275.70M
Capital Expenditure	-$75.70M	-$58.20M	-$33.80M	-$45.30M
Free Cash Flow	$107.00M	$217.50M	$302.70M	$230.40M
Depreciation & Amortisation	$162.10M	$162.60M	$154.50M	$150.70M
Stock-Based Compensation	$30.50M	$30.70M	$35.30M	$37.60M
Investing Cash Flow	-$657.30M	-$62.40M	-$54.60M	-$51.10M
Financing Cash Flow	$12.50M	$118.90M	-$103.70M	-$170.90M
Share Repurchases	—	$0.00	$0.00	-$166.60M
Net Change in Cash	-$462.10M	$332.20M	$178.20M	$53.70M

NVST Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$616.90M	$682.10M	$669.90M	$750.60M	$705.50M
Cost of Revenue	$280.90M	$312.20M	$299.70M	$340.00M	$315.40M
Gross Profit	$336.00M	$369.90M	$370.20M	$410.60M	$390.10M
Research & Development	$25.30M	$28.30M	$28.30M	$32.10M	$30.00M
Selling, General & Admin	$263.30M	$295.30M	$284.40M	$285.50M	$293.90M
Operating Expenses	$288.60M	$323.60M	$312.70M	$317.60M	$323.90M
Operating Income	$47.40M	$46.30M	$57.50M	$93.00M	$66.20M
EBITDA	$74.60M	$87.30M	$96.70M	$105.90M	$97.90M
Pretax Income	$29.00M	$40.70M	$49.90M	$57.60M	$52.20M
Income Tax	$11.00M	$14.30M	$80.20M	$24.70M	$13.50M
Net Income	$18.00M	$26.40M	-$30.30M	$32.90M	$38.70M
Diluted EPS	0.10	0.16	-0.18	0.20	0.23
Diluted Shares	173.60M	169.90M	166.10M	166.00M	166.40M

NVST Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$1.08B	$1.11B	$1.13B	$1.21B	$1.08B
Receivables	$393.10M	$422.80M	$405.90M	$429.60M	$436.60M
Inventory	$261.30M	$281.90M	$290.80M	$288.10M	$300.30M
Current Assets	$1.85B	$1.93B	$1.95B	$2.03B	$1.92B
Total Assets	$5.47B	$5.66B	$5.64B	$5.68B	$5.58B
Current Liabilities	$873.30M	$793.90M	$821.70M	$852.60M	$786.60M
Long-Term Debt	$1.30B	$1.45B	$1.45B	$1.45B	$1.44B
Total Debt	$1.56B	$1.60B	$1.60B	$1.60B	$1.59B
Total Liabilities	$2.43B	$2.53B	$2.55B	$2.57B	$2.50B
Retained Earnings	-$469.40M	-$443.00M	-$473.30M	-$440.40M	-$401.70M
Shareholders' Equity	$3.04B	$3.14B	$3.09B	$3.11B	$3.08B
Working Capital	$976.40M	$1.14B	$1.13B	$1.17B	$1.13B
Net Debt	$334.70M	$334.50M	$311.50M	$236.60M	$356.30M

NVST Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$300.00K	$88.70M	$78.70M	$108.00M	-$3.30M
Capital Expenditure	-$5.90M	-$12.30M	-$10.80M	-$16.30M	-$12.50M
Free Cash Flow	-$5.60M	$76.40M	$67.90M	$91.70M	-$15.80M
Depreciation & Amortisation	$36.30M	$38.60M	$37.80M	$38.00M	$38.30M
Stock-Based Compensation	$7.10M	$9.70M	$10.40M	$10.40M	$10.20M
Investing Cash Flow	-$8.80M	-$17.10M	-$9.70M	-$15.50M	-$68.90M
Financing Cash Flow	-$17.60M	-$86.40M	-$41.70M	-$25.20M	-$45.60M
Share Repurchases	-$14.60M	-$85.70M	-$42.00M	-$24.30M	-$42.70M
Net Change in Cash	-$26.10M	-$14.80M	$27.30M	$67.30M	-$117.80M

Market Snapshot

About

Envista Holdings Corp. is a global dental products and technologies company that manufactures and sells dental consumables, equipment, and specialty products. The company operates through well-known brands including Nobel Biocare (implants), Ormco (orthodontics), and KaVo Kerr (equipment and instruments). Envista serves dental professionals and laboratories worldwide with solutions spanning prevention, diagnosis, treatment, and digital dentistry.